By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endonovo Therapeutics 

Los Angeles   California    U.S.A.
Phone: n/a Fax: n/a



Company News
Endonovo Files A New Patent Application On Method To Treat Tissues And Organs Using Its Non-Invasive Electroceutical Technology 3/24/2017 9:22:50 AM
Endonovo Evaluating Therapeutic Potential Of Non-Invasive Electroceutical Device Following Myocardial Infarction 12/19/2016 12:03:13 PM
Endonovo Signs Term Sheet For $5 Million To Redeem All Outstanding Convertible Notes And Prepare To Uplist Its Common Stock 11/29/2016 11:19:02 AM
Endonovo: Targeting $20+ Billion Market For In Vitro ADME And Toxicology Testing 11/8/2016 10:56:09 AM
SoCal's Endonovo Rakes in $10 Million 10/14/2016 12:05:41 PM
Endonovo At The Intersection Of Stem Cells And Biologics For Next Generation Therapeutics - 9/29/2016 11:29:02 AM
Rio Grande Neurosciences Backs Out of $22 Million Endonovo Buyout Deal 8/22/2016 6:00:57 AM
Endonovo Files Patent For Treating Chemical And Radiation Injuries Using Next-Generation Biologics 8/11/2016 9:08:12 AM
Endonovo Announces Issuance Of U.S. Patent On Production Of Human Biomolecules 8/9/2016 11:02:01 AM
Endonovo Announces New Round Of Financing 7/18/2016 10:23:18 AM